Literature DB >> 17969161

Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis.

Hale Ersoy1, Frank J Rybicki.   

Abstract

Gadolinium (Gd)-based paramagnetic contrast agents are relatively safe when used in clinically recommended doses. However, with the rapidly expanding body of literature linking Gd-based paramagnetic contrast agents and nephrogenic systemic fibrosis (NSF), awareness of the potential side effects and adverse reactions from Gd is now an important requirement for practicing radiologists. In addition to the ongoing accumulation and analyses of clinical NSF data, it is also essential for the practicing radiologist to understand the biochemical characteristics of the extracellular Gd-chelates. The purpose of this review is to consolidate and update the available information on known side effects, adverse reactions, and toxicity of the Gd chelates, with particular emphasis on the potential mechanisms of NSF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17969161      PMCID: PMC2709982          DOI: 10.1002/jmri.21135

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  90 in total

Review 1.  Contrast agents for magnetic resonance imaging: safety update.

Authors:  Miles A Kirchin; Val M Runge
Journal:  Top Magn Reson Imaging       Date:  2003-10

2.  Effects of lanthanum and gadolinium ions on cardiac sarcoplasmic reticulum.

Authors:  N Krasnow
Journal:  Biochim Biophys Acta       Date:  1972-09-01

Review 3.  Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia?

Authors:  Ulf Nyman; Barbara Elmståhl; Peter Leander; Mats Nilsson; Klaes Golman; Torsten Almén
Journal:  Radiology       Date:  2002-05       Impact factor: 11.105

4.  Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy.

Authors:  Wendell A Gibby; Krissa A Gibby; W Andrew Gibby
Journal:  Invest Radiol       Date:  2004-03       Impact factor: 6.016

5.  Gadodiamide administration causes spurious hypocalcemia.

Authors:  Martin R Prince; Hale E Erel; Richard W Lent; Jon Blumenfeld; K Craig Kent; Harry L Bush; Yi Wang
Journal:  Radiology       Date:  2003-06       Impact factor: 11.105

6.  Safety of gadolinium contrast angiography in patients with chronic renal insufficiency.

Authors:  Albert D Sam; Mark D Morasch; Jeremy Collins; Gina Song; Richard Chen; F Scott Pereles
Journal:  J Vasc Surg       Date:  2003-08       Impact factor: 4.268

7.  An investigation of the toxicity of gadolinium based MRI contrast agents using neutron activation analysis.

Authors:  M E Bartolini; J Pekar; D R Chettle; F McNeill; A Scott; J Sykes; F S Prato; G R Moran
Journal:  Magn Reson Imaging       Date:  2003-06       Impact factor: 2.546

8.  Gadolinium-containing contrast media for radiographic examinations: a position paper.

Authors:  Henrik S Thomsen; Torsten Almèn; Sameh K Morcos
Journal:  Eur Radiol       Date:  2002-08-16       Impact factor: 5.315

9.  Local tissue toxicity in response to extravascular extravasation of magnetic resonance contrast media.

Authors:  Val M Runge; Kenneth M Dickey; Neil M Williams; Xuejun Peng
Journal:  Invest Radiol       Date:  2002-07       Impact factor: 6.016

10.  Gadolinium magnetic resonance contrast agents produce analytic interference in multiple serum assays.

Authors:  Kerry A S Proctor; Lokinendi V Rao; William L Roberts
Journal:  Am J Clin Pathol       Date:  2004-02       Impact factor: 2.493

View more
  64 in total

Review 1.  Gadolinium-based contrast agents: did we miss something in the last 25 years?

Authors:  Bruno Beomonte Zobel; Carlo Cosimo Quattrocchi; Yuri Errante; Rosario Francesco Grasso
Journal:  Radiol Med       Date:  2015-12-26       Impact factor: 3.469

2.  Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.

Authors:  Sohi Bae; Ho-Joon Lee; Kyunghwa Han; Yae-Won Park; Yoon Seong Choi; Sung Soo Ahn; Jinna Kim; Seung-Koo Lee
Journal:  Eur Radiol       Date:  2017-01-12       Impact factor: 5.315

3.  Magnetic resonance imaging contrast enhancement in vitro and in vivo by octanuclear iron-oxo cluster-based agents.

Authors:  Soma Das; Kenia Parga; Indranil Chakraborty; Arthur D Tinoco; Yamixa Delgado; Paola M López; Lauren Fernández Vega; Yiannis Sanakis; Sukhen Ghosh; Jim Bankson; Jim Klostergaard; Ricardo González-Méndez; Raphael G Raptis
Journal:  J Inorg Biochem       Date:  2018-06-26       Impact factor: 4.155

4.  A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors.

Authors:  Xiangdong Xue; Ruonan Bo; Haijing Qu; Bei Jia; Wenwu Xiao; Ye Yuan; Natalia Vapniarsky; Aaron Lindstrom; Hao Wu; Dalin Zhang; Longmeng Li; Marina Ricci; Zhao Ma; Zheng Zhu; Tzu-Yin Lin; Angelique Y Louie; Yuanpei Li
Journal:  Biomaterials       Date:  2020-07-15       Impact factor: 12.479

5.  The application of T2W SPIR-FLAIR in the diagnosis of hip synovitis in patients with spondyloarthritis.

Authors:  Zhen-Guo Huang; Xiao-Liang Chen; Kai-Ning Shi; Ran Yan; He Chen; Min-Xing Yang; Bao-Xiang Gao; Queenie Chan; Guo-Chun Wang
Journal:  Br J Radiol       Date:  2016-09-23       Impact factor: 3.039

6.  Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents.

Authors:  Emmanuil Smorodinsky; David S Ansdell; Zeke W Foster; Sameer M Mazhar; Irene Cruite; Tanya Wolfson; Sebastian B Sugay; Gabriella Iussich; Masoud Shiehmorteza; Yuko Kono; Alexander Kuo; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2014-05-09       Impact factor: 4.813

Review 7.  Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.

Authors:  Ahmed Ba-Ssalamah; Martin Uffmann; Sanjai Saini; Nina Bastati; Christian Herold; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

Review 8.  Imaging features of intramural hematoma of the aorta.

Authors:  Orla Buckley; Frank J Rybicki; David S Gerson; Colleen Huether; Richard F Prior; Sara L Powers; Hale Ersoy
Journal:  Int J Cardiovasc Imaging       Date:  2009-09-24       Impact factor: 2.357

Review 9.  Novel contrast mechanisms at 3 Tesla and 7 Tesla.

Authors:  Ravinder R Regatte; Mark E Schweitzer
Journal:  Semin Musculoskelet Radiol       Date:  2008-10-10       Impact factor: 1.777

10.  Physicians' awareness of gadolinium retention and MRI timing practices in the longitudinal management of pituitary tumors: a "Pituitary Society" survey.

Authors:  Lisa B Nachtigall; Niki Karavitaki; Katja Kiseljak-Vassiliades; Luma Ghalib; Hidenori Fukuoka; Luis V Syro; Daniel Kelly; Maria Fleseriu
Journal:  Pituitary       Date:  2019-02       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.